ADC Therapeutics (ADCT) POS AM Prospectus update (post-effective amendment)

Exhibit 107

Calculation of Filing Fee Tables

POS AM

(Form Type)

ADC Therapeutics SA

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to be Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

Equity

Common Shares

Rule 415(a)

1,260,863 (1)

$8,762,997.85

F-3

333-267295

September 16, 2022

$812.33

Total Offering Amounts

$8,762,997.85

$812.33

Total Fees Previously Paid

$812.33

Total Fee Offsets

$0

Net Fee Due

$0

(1)       Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, the Registrant is also registering hereunder an indeterminate number of common shares that may be issued in connection with anti-dilution provisions or stock splits, stock dividends or similar transactions.